MoneyWorks4Me

Lupin - Quaterly Results

07 Nov 2024 Evaluate
The revenue for the September 2024 quarter is pegged at Rs. 41062.00 millions, about 12.21% up against Rs. 36592.30 millions recorded during the year-ago period.A good growth in profit of 47.24% reported to Rs. 8077.60  millions over Rs. 5486.10 millions of corresponding previous quarter.Operating profit surged to 11473.70 millions from the corresponding previous quarter of 8608.40 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 41062.00 36592.30 12.21 82738.30 71548.70 15.64 146665.00 112588.30 30.27
Other Income 326.20 256.00 27.42 717.00 533.40 34.42 1067.30 912.60 16.95
PBIDT 11473.70 8608.40 33.28 23852.60 15936.00 49.68 35657.90 11739.20 203.75
Interest 175.50 153.20 14.56 311.00 315.00 -1.27 563.50 984.40 -42.76
PBDT 11298.20 8455.20 33.62 23541.60 15621.00 50.70 35094.40 10754.80 226.31
Depreciation 1457.70 1494.80 -2.48 2871.90 2895.30 -0.81 7247.50 5483.40 32.17
PBT 9840.50 6960.40 41.38 20669.70 12725.70 62.42 27846.90 5271.40 428.26
TAX 1762.90 1474.30 19.58 3700.30 2470.00 49.81 4586.00 1019.30 349.92
Deferred Tax 43.40 177.70 -75.58 88.90 166.20 -46.51 -254.50 60.40 -521.36
PAT 8077.60 5486.10 47.24 16969.40 10255.70 65.46 23260.90 4252.10 447.04
Equity 912.30 910.50 0.20 912.30 910.50 0.20 911.40 910.00 0.15
PBIDTM(%) 27.94 23.53 18.78 28.83 22.27 29.44 24.31 10.43 133.18
Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1250.00
Cipla 1383.00
Lupin 2060.00
Zydus Lifesciences 1195.20
View more..